Metaniff MP Cream contains Mometasone Furoate 0.1% w/w, a potent topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Methyl Paraben and Propyl Paraben act as preservatives, ensuring product stability and preventing microbial contamination.
Clinically, this cream is indicated for inflammatory and pruritic skin conditions such as eczema, dermatitis, psoriasis, and allergic skin reactions. Its potent anti-inflammatory action reduces redness, swelling, and itching, providing rapid symptomatic relief.
The cream formulation ensures uniform application, optimal skin penetration, and sustained therapeutic effect, making it suitable for dermatology clinics, hospitals, and outpatient skin care centers. Its preservative combination maintains microbial safety and shelf stability.
Metaniff MP Cream helps in reducing skin inflammation, relieving itching, restoring skin comfort, and supporting healing of affected areas. With a favorable safety profile under supervised use, it is a trusted topical therapy for dermatological care.